Follow
Isaac Woodhouse
Isaac Woodhouse
Senior Computational Biologist / Data Analyst, Nuffield Department of Medicine
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
CiiiDER: A tool for predicting and analysing transcription factor binding sites
LJ Gearing, HE Cumming, R Chapman, AM Finkel, IB Woodhouse, K Luu
PLoS ONE 14 (9), e0215495, 2019
1622019
Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
CH Lee, MP Pinho, PR Buckley, IB Woodhouse, G Ogg, A Simmons, ...
Frontiers in immunology 11, 579480, 2020
552020
Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19
AKH Wong, I Woodhouse, F Schneider, DA Kulpa, G Silvestri, CL Maier
Cell Reports Medicine 2 (6), 2021
27*2021
Acute experimental infection of bats and ferrets with Hendra virus: Insights into the early host response of the reservoir host and susceptible model species
AP Woon, V Boyd, S Todd, I Smith, R Klein, IB Woodhouse, S Riddell, ...
PLoS pathogens 16 (3), e1008412, 2020
272020
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell–mediated toxicity against glioblastoma
R Ma, M Rei, I Woodhouse, K Ferris, S Kirschner, A Chandran, U Gileadi, ...
Neuro-oncology 24 (12), 2093-2106, 2022
222022
Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens
PR Buckley, CH Lee, R Ma, I Woodhouse, J Woo, VO Tsvetkov, ...
Briefings in Bioinformatics 23 (3), bbac141, 2022
222022
HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes
V Karnaukhov, W Paes, IB Woodhouse, T Partridge, A Nicastri, ...
Frontiers in Immunology 13, 1067463, 2022
15*2022
Ionizing radiation drives key regulators of antigen presentation and a global expansion of the immunopeptidome
A Tailor, H Estephan, R Parker, I Woodhouse, M Abdulghani, A Nicastri, ...
Molecular & Cellular Proteomics 21 (11), 2022
72022
Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer
X Peng, I Woodhouse, G Hancock, R Parker, K Marx, J Müller, S Salatino, ...
Iscience 26 (3), 2023
52023
MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer
H Liao, C Barra, Z Zhou, X Peng, I Woodhouse, A Tailor, R Parker, ...
Nature Communications 15 (1), 661, 2024
4*2024
A de-risking experimental framework defines the physiological interactome of TCR-based therapeutics in human tissues
E Marrer-Berger, A Nicastri, A Augustin, V Pulko, H Liao, L Duerner, ...
12022
The physiological interactome of TCR-like antibody therapeutics in human tissues
E Marrer-Berger, A Nicastri, A Augustin, V Kramar, H Liao, LJ Hanisch, ...
Nature Communications 15 (1), 3271, 2024
2024
First-in-class inhibitors of ERAP1 alter the HLA-I-restricted cancer immunopeptidome leading to the generation of novel peptides presented for immune recognition
W Paes, A Leishman, K Anderton, H Liao, I Woodhouse, R Parker, ...
Cancer Research 82 (12_Supplement), 4153-4153, 2022
2022
Interferon epsilon in the regulation of mucosal innate immune responses in the female reproductive tract
N Mangan, E De Geus, L Mielke, J Gould, H Cumming, I Woodhouse, ...
Cytokine 100, 162-163, 2017
2017
Novel Canonical and Non-Canonical Antigens That Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer
X Peng, I Woodhouse, G Hancock, R Parker, J Muller, S Salatino, ...
Available at SSRN 4022700, 0
The system can't perform the operation now. Try again later.
Articles 1–15